Exploring the Real-World Effectiveness of Empagliflozin and Linagliptin Fixed-Dose Combination in Type 2 Diabetes Patients of Bangladesh: A Prospective Multi-Center Observational Study

Empa/Lina (10/5) FDC demonstrated significant improvements in glycemic control, BMI, and blood pressure with a favorable safety profile in Bangladeshi patients with T2DM. These real-world findings support its use as an effective treatment option in this population.

Authors

Institutions

Publication Details

Journal
Diabetes Metabolic Syndrome and Obesity
Published
2025-12-01
DOI
https://doi.org/10.2147/dmso.s542107
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring the Real-World Effectiveness of Empagliflozin and Linagliptin Fixed-Dose Combination in Type 2 Diabetes Patients of Bangladesh: A Prospective Multi-Center Observational Study

Rezaul Haider, Md Zainal Abedin, Khondoker Alam, Mobarak Hosen et al.
Diabetes Metabolic Syndrome and Obesity
Diabetes Treatment and Management
article

Exploring the Real-World Effectiveness of Empagliflozin and Linagliptin Fixed-Dose Combination in Type 2 Diabetes Patients of Bangladesh: A Prospective Multi-Center Observational Study

Rezaul Haider, Md Zainal Abedin, Khondoker Alam, Mobarak Hosen, Dahlia Sultana, Nazmul Kabir Qureshi, Shamimunisa B. Mustafa, Shoma Sharker, Farhana Afrooz, Shamail Zafar, Mirza Sharifuzzaman, Md Saruar Bhuiyan, M. Belal Hossain, Md. Abul Kashem, Aysha Begum, Shahjada Selim, Farhana Akter, Fouzia Anar, Afsar Ahammed, Ajit Paul, AFM Nazmul Islam, Md. Rakibul Hasan, Md. Motiur Rahman, Mohammad Saifuddin, Md Abu Zahid, Sunjida Islam, Md Akteruzzaman, ASM Musa Kobir
article en

Abstract

Empa/Lina (10/5) FDC demonstrated significant improvements in glycemic control, BMI, and blood pressure with a favorable safety profile in Bangladeshi patients with T2DM. These real-world findings support its use as an effective treatment option in this population.

Diabetes Metabolic Syndrome and ObesityVol. Volume 18
Khulna University (BD), Khulna University of Engineering and Technology (BD), Rajshahi Medical College (BD), Bangladesh University (BD), Bangladesh Medical University (BD), Sylhet MAG Osmani Medical College (BD), North East University (BD), Hamdard University Bangladesh (BD), Chittagong Medical College (BD), Comilla Medical College (BD), National University Bangladesh (BD), Bangladesh Institute of Research and Rehabilitation for Diabetes Endocrine and Metabolic Disorders (BD), Dinajpur Medical College (BD), Khulna Medical College (BD), Noakhali Science and Technology University (BD), Islamic University (BD), Chattagram Maa-O-Shishu Hospital Medical College (BD), Bangladesh University of Health Sciences (BD), Nini Hospital (LB), Directorate General of Health Services (BD), Shaheed Suhrawardy Medical College (BD), Sir Salimullah Medical College, Rangpur Medical College, Dhaka Medical College and Hospital (BD)
Openalex Percentile: Top 50%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.